Europe’s Declaration on Pharmaceuticals in the Environment

CCB • November 17, 2017

20 Organisations sign declaration expressing serious concern about pharmaceuticals in the environment in the EU

17th November 2017
Brussels

A group of twenty organisations – lead by Health Care Without Harm (HCWH) Europe – today sent a Declaration to European Commissioner for Environment, Maritime Affairs and Fisheries, Karmenu Vella, expressing their deep concern about the threat posed by pharmaceuticals in the environment to  European citizens, their communities, and the environment. The Declaration comes during World Antibiotic Awareness Week and on the eve of European Antibiotic Awareness Day.

The consortium of organisations, which is made up of hospitals, health organisations, professional health and student associations, and health and environment NGOs, wrote to the Commissioner to highlight the importance of introducing ambitiouslegislation in the upcoming Strategic Approach to Pharmaceuticals in the Environment (due to be released in early 2018).

The Declaration also highlights the unintended consequences of the release of increasing amounts of pharmaceuticals into the environment on both human and environmental health.
Pharmaceuticals in the environment represent a global pollution – over 631 different pharmaceutical agents or their metabolites have been detected in 71 countries on all continents.
The European Union is one of the largest consumers of human medicinal products in the world (24% of the global production), second only to the U.S. Pharmaceutical pollution, however, is an unrestricted cross-border phenomenon that affects all countries.

Active Pharmaceutical Ingredients (APIs, the part of the medicine that is biologically active in order to have an effect on the body) are designed to be biologically active and often remain unchanged during their passage through the body. These APIs can also enter the environment during the production phase (through wastewater) and when medicines are disposed of incorrectly (by flushing down the toilet or sink).

Even low concentrations of pharmaceuticals in the environment can have farreaching effects on ecosystems – causing reproductive failure, growth inhibition, behavioural changes, and species’ population collapse, such as the near extinction of vultures feeding on animals that have been treated with diclofenac in Pakistan.

As well as outlining the problems associated with pharmaceuticals in the environment, the group also propose solutions in the Declaration, in the form of a comprehensive set of policy recommendations, stating that: “We, the undersigned, strongly believe that [these] recommendations should be incorporated into the ‘Strategic Approach to Pharmaceuticals in the Environment’. EU citizens have the right to live in a safe environment in order to prevent sickness and the spread of AMR. We therefore call on the European Commission to consider our position on this issue and take immediate action to protect human and environmental health.”

Speaking of the Declaration, HCWH Europe Executive Director Anja Leetz said: “Pharmaceuticals in the environment are a global pollution problem which needs to be addressed immediately. By allowing this known problem to continue we are running a global experiment with no control group. We do not know enough about the long-term and cumulative cocktail effects of small amounts of pharmaceutical residues in our water and food supply and we need to apply the precautionary principle and reduce exposure where possible. We urgently need to minimise the release of pharmaceuticals into the environment at all stages of their life cycle in order to limit the potential damage to human or environmental health.”

Read Europe’s Declaration on Pharmaceuticals in the Environment here

The Declaration is co-signed by:
• Aarhus University Hospital (Denmark)
• Doctors for the Environment (AEFU) (Switzerland)
• Aufbruch – anders besser leben (Germany)
• Comité pour le Développement Durable en Santé (C2DS) (France)
• Center for Environmental Solutions (Belarus)
• Changing Markets
• Coalition Clean Baltic
• European Environmental Bureau (EEB)
• European Public Health Alliance (EPHA)
• European Academy for Environmental Medicine (Germany)
• Fundación Alborada (Spain)
• Health Action International (HAI)
• Health and Environment Alliance (HEAL)
• Health Care Without Harm (HCWH) Europe
• International HCH and Pesticide Association (IHPA)
• IndyACT (Lebanon)
• IPEN (Toxics-Free Network)
• The International Pharmaceutical Students Federation (IPSF)
• Ökologischer Ärztebund e.V. (ISDE Germany)
• Pestizid Aktions-Netzwerk (PAN Germany)

PRESS CONTACT
Aidan Long, Press and Communications Manager – HCWH Europe
Email: aidan.long@hcwh.org
Phone: +32 465 10 09 40

Further information from CCB is availiable from
Eugeniy Lobanov, CCB Working Area Leader for Hazardous Substances and Marine Litter

Email:  lobanow@gmail.comlobanow@ecoidea.by

 

By CCB April 9, 2025
Coalition Clean Baltic – CCB is a politically independent network, uniting 27 environmental non-profit organizations, as well as partners and experts from 11 countries surrounding the Baltic Sea. The main goal of CCB is to promote the protection and improvement of the environment and natural resources of the Baltic Sea region by encouraging new and constructive approaches and engaging people to become part of the solution instead of part of the problem. CCB Secretariat is based in Uppsala, Sweden.
By CCB April 7, 2025
European civil society organisations (CSOs) are currently facing an attack coming from certain Members of the European Parliament. Spearheaded by some MEPs from the European People’s Party (EPP) and by far-right groups, this attack resorts to misleading arguments to fabricate a scandal. This portrayal has been amplified through the media, with notable exceptions of articles that attempted to clarify this misleading narrative. European CSOs are crucial to ensure the voices of citizens from different parts of Europe are heard in the EU institutions. Attacks against civil society are unfortunately not new and are exacerbated by this harmful idea. Furthermore, for-profit corporate lobbying is through the roof when compared to non-profit advocacy. In 2024, the 50 corporations with the largest lobbying budgets collectively spent nearly €200 million on lobbying the EU alone (66% more than in 2015). Comparing this to the funding environmental NGOs receive under the LIFE programme - €15.6 million annually of a €700 million yearly budget - truly shows the weakness of this ‘scandal’. This is why over 570 civil society organisations from 40 countries, including all EU Member States, have joined forces to call on those in power to act now and ensure that civil society is adequately funded and enabled to share our crucial perspectives . In this statement, we address: The source of this false narrative; Inaccurate claims made about how CSOs obtain and use funding; Why it’s paramount that CSOs receive sufficient funding; The need for civil dialogue to enable CSOs participation. Democracy is about the right of citizens to be collectively heard for building an inclusive society and a shared European future; properly funded independent CSOs are a crucial tool for that. We call on decision-makers to ensure civil society organisations can thrive and play their role in interacting with policy-makers in order to have a more fully informed decision-making process. Read the full statement here . -END Civil Society Europe (CSE) is the coordination of civil society organisations at EU level. Through its membership, CSE unites EU-level membership-based organisations that reach out to millions of people active in or supported by not-for-profits and civil society organisations across the EU. CSE was created by several civil society organisations as a follow-up to the European Year of Citizens and was established as an international not-for-profit under Belgian law in 2016. Since then, it has become the point of reference for EU institutions on transversal issues concerning civil dialogue and civic space.